These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11380644

  • 1. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR, Lake AE, Tepper SJ.
    Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644
    [Abstract] [Full Text] [Related]

  • 2. An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache.
    Saper JR, Winner PK, Lake AE.
    Headache; 2001 Apr; 41(4):357-68. PubMed ID: 11318882
    [Abstract] [Full Text] [Related]

  • 3. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
    Saper JR, Lake AE, Cantrell DT, Winner PK, White JR.
    Headache; 2002 Jun; 42(6):470-82. PubMed ID: 12167135
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [Abstract] [Full Text] [Related]

  • 5. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Rickels K, Schweizer E, Case WG, DeMartinis N, Greenblatt DJ, Mandos LA, Garcia España FG.
    J Clin Psychopharmacol; 1998 Apr; 18(2):145-53. PubMed ID: 9580369
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 7. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
    Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F.
    CNS Drugs; 2002 Jun; 16(9):635-43. PubMed ID: 12153334
    [Abstract] [Full Text] [Related]

  • 8. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder.
    Gillin JC, Smith-Vaniz A, Schnierow B, Rapaport MH, Kelsoe J, Raimo E, Marler MR, Goyette LM, Stein MB, Zisook S.
    J Clin Psychiatry; 2001 Oct; 62(10):789-96. PubMed ID: 11816868
    [Abstract] [Full Text] [Related]

  • 9. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
    Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin, Keller B.
    Sleep; 2003 Mar 15; 26(2):130-6. PubMed ID: 12683470
    [Abstract] [Full Text] [Related]

  • 10. Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
    Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, Kline NA, Ellenor GL, Kodsi AB, Gillin JC.
    J Clin Psychiatry; 2000 Mar 15; 61(3):203-8. PubMed ID: 10817106
    [Abstract] [Full Text] [Related]

  • 11. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.
    J Clin Psychiatry; 1997 May 15; 58(5):185-92. PubMed ID: 9184611
    [Abstract] [Full Text] [Related]

  • 12. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group.
    Headache; 2010 Jun 15; 50(6):921-36. PubMed ID: 20487038
    [Abstract] [Full Text] [Related]

  • 13. A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression.
    Goldberg JF.
    J Affect Disord; 2013 Jan 10; 144(1-2):176-8. PubMed ID: 22858262
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.
    Boudreau GP, Grosberg BM, McAllister PJ, Lipton RB, Buse DC.
    Int J Gen Med; 2015 Jan 10; 8():79-86. PubMed ID: 25733924
    [Abstract] [Full Text] [Related]

  • 15. Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.
    Davis LL, Nugent AL, Murray J, Kramer GL, Petty F.
    J Clin Psychopharmacol; 2000 Apr 10; 20(2):159-64. PubMed ID: 10770453
    [Abstract] [Full Text] [Related]

  • 16. A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.
    Lampl C, Marecek S, May A, Bendtsen L.
    Cephalalgia; 2006 Oct 10; 26(10):1203-8. PubMed ID: 16961787
    [Abstract] [Full Text] [Related]

  • 17. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, Cowley DS, Ries RK.
    J Clin Psychopharmacol; 2000 Apr 10; 20(2):129-36. PubMed ID: 10770449
    [Abstract] [Full Text] [Related]

  • 18. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
    Lespérance F, Frasure-Smith N, Laliberté MA, White M, Lafontaine S, Calderone A, Talajic M, Rouleau JL.
    Can J Psychiatry; 2003 Nov 10; 48(10):695-701. PubMed ID: 14674053
    [Abstract] [Full Text] [Related]

  • 19. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
    Pallanti S, Baldini Rossi N, Sood E, Hollander E.
    J Clin Psychiatry; 2002 Nov 10; 63(11):1034-9. PubMed ID: 12444818
    [Abstract] [Full Text] [Related]

  • 20. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun 10; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.